You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Bal Pharma Ltd"

Bal Pharma Ltd Statement Of Investor Complaints For The Quarter Ended June 2022

  • 01/07/2022
  • |
  • bse

Bal Pharma Ltd Closure of Trading Window

  • 28/06/2022
  • |
  • bse

Bal Pharma Ltd Disclosure Of Related Party Transactions_31.03.2022

  • 14/06/2022
  • |
  • bse

Bal Pharma Ltd Declaration Of Unmodified Opinion_ Audited Financial Results

  • 08/06/2022
  • |
  • bse

Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 01/06/2022
  • |
  • bse

Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release

  • 31/05/2022
  • |
  • bse

Bal Pharma Ltd Audited Financial Results For F.Y 2021-22.

  • 30/05/2022
  • |
  • bse

Bal Pharma Ltd Board Meeting Outcome for Out Come Of The Board Meeting

  • 30/05/2022
  • |
  • bse

Bal Pharma Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance

  • 26/05/2022
  • |
  • bse

Bal Pharma Ltd Certificate As Per Regulation 40(9) Of SEBI(LODR) Regulations2015.

  • 19/04/2022
  • |
  • bse

Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Allotment

  • 13/04/2022
  • |
  • bse

Bal Pharma Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 13/04/2022
  • |
  • bse

Bal Pharma Ltd Compliance With Regulation 7(3) Of SEBI(LODR) Regulations.

  • 06/04/2022
  • |
  • bse

Bal Pharma Ltd Board Meeting Intimation for Allotment Of Equity Shares Upon Conversion Of Warrants.

  • 05/04/2022
  • |
  • bse

Bal Pharma Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 04/04/2022
  • |
  • bse

Bal Pharma Ltd Statement Of Investor Complaints For The Quarter Ended March 2022

  • 04/04/2022
  • |
  • bse

Bal Pharma Ltd Closure of Trading Window

  • 31/03/2022
  • |
  • bse

Bal Pharma Ltd Board Meeting Outcome for Out Come Of The Board Meeting-Approval For Amalgamation Of Golden Drugs Pv

  • 09/03/2022
  • |
  • bse

Bal Pharma Ltd Board Meeting Intimation for Approval Of Scheme Of Amalgamation.

  • 28/02/2022
  • |
  • bse

Bal Pharma Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 25/02/2022
  • |
  • bse
.